［1］ SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023［J］.CA A Cancer J Clinicians,2023,73(1):17-48.
［2］ HEATH H,MOGOL AN,SANTALIZ CA,et al.Targeting systemic and gut microbial metabolism in ER+ breast cancer［J］.Trends Endocrinol Metab,2024,35(4):321-330.
［3］ ANDERSON WF,CHATTERJEE N,ERSHLER WB,et al.Estrogen receptor breast cancer phenotypes in the surveillance,epidemiology,and end results database［J］.Breast Cancer Res Treat,2002,76(1):27-36.
［4］ MCGRATH MK,ABOLHASSANI A,GUY L,et al.Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer［J］.Front Endocrinol,2024,15:1298423.
［5］ LEI JT,ANURAG M,HARICHARAN S,et al.Endocrine therapy resistance:new insights［J］.The Breast,2019,48:S26-S30.
［6］ PLOTTEL CS,BLASER MJ.Microbiome and malignancy［J］.Cell Host & Microbe,2011,10(4):324-335.
［7］ BUCHTA RC,BOSTIC RR,FEREY JCM,et al.Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer［J］.Cancer Research,2019,79(14):3662-3675.
［8］ RUSSO J,RUSSO IH.The role of estrogen in the initiation of breast cancer［J］.The Journal of Steroid Biochemistry and Molecular Biology,2006,102(1-5):89-96.
［9］ FURTH PA,CABRERA MC,DIAZ-CRUZ ES,et al.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models［J］.Annals of the New York Academy of Sciences,2011,1229(1):147-155.
［10］ SAMAVAT H,KURZER MS.Estrogen metabolism and breast cancer［J］.Cancer Letters,2015,356(2):231-243.
［11］ FUNK JL,WERTHEIM BC,FRYE JB,et al.Association of β-glucuronidase activity with menopausal status,ethnicity,adiposity,and inflammation in women［J］.Menopause,2023,30(2):186-192.
［12］ KWA M,PLOTTEL CS,BLASER MJ,et al.The intestinal microbiome and estrogen receptor-positive female breast cancer［J］.Journal of the National Cancer Institute,2016,108(8)：1-10.
［13］ LABORDA-ILLANES A,SANCHEZ-ALCOHOLADO L,DOMINGUEZ-RECIO ME,et al.Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment［J］.Cancers,2020,12(9):2465.
［14］ AWOLADE P,CELE N,KERRU N,et al.Therapeutic significance of β-glucuronidase activity and its inhibitors:A review［J］.Eur J Med Chem,2020,187:111921.
［15］ ARNONE AA,COOK KL.Gut and breast microbiota as endocrine regulators of hormone receptor-positive breast cancer risk and therapy response［J］.Endocrinology,2022,164(1):bqac177.
［16］ PARIDA S,WU S,SIDDHARTH S,et al.A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes［J］.Cancer Discov,2021,11(5):1138-1157.
［17］ LARKINS TL,NOWELL M,SINGH S,et al.Inhibition of cyclooxygenase-2 decreases breast cancer cell motility,invasion and matrix metalloproteinase expression［J］.BMC Cancer,2006,6:181.
［18］ BARROSO-SOUSA R,LI T,DAMANIA AV,et al.Abstract PD11-05:PD11-05 Gut microbiome signatures correlate with overall survival among patients receiving eribulin with or without pembrolizumab for hormone receptor-positive metastatic breast cancer［J］.Cancer Research,2023,83(5_supplement):PD11-05.
［19］ QIU Q,LIN Y,MA Y,et al.Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy［J］.Front Immunol,2020,11:612202.
［20］ MIKO E,KOVACS T,SEBO E,et al.Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar,but unexplored［J］.Cells,2019,8(4):293.
［21］ LI H,GAO X,CHEN Y,et al.Potential risk of tamoxifen:gut microbiota and inflammation in mice with breast cancer［J］.Front Oncol,2023,13:1121471.
［22］ SCHETTINI F,FONTANA A,GATTAZZO F,et al.Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer:A prospective cross-sectional exploratory study［J］.Eur J Cancer,2023,191:112948.
［23］ LASAGNA A,DE AMICI M,ROSSI C,et al.The bio-diversity and the role of gut microbiota in postmenopausal women with luminal breast cancer treated with aromatase inhibitors:an observational cohort study［J］.Pathogens,2022,11(12):1421.
［24］ VILHAIS G,ALPUIM CD,FONTES-SOUSA M,et al.Case report:Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota［J］.Front Oncol,2024,14:1360737.
［25］ POIROT M,SILVENTE-POIROT S,WEICHSELBAUM RR.Cholesterol metabolism and resistance to tamoxifen［J］.Current Opinion in Pharmacology,2012,12(6):683-689.
［26］ JOHNSON KE,SIEWERT KM,KLARIN D,et al.The relationship between circulating lipids and breast cancer risk:A Mendelian randomization study［J］.PLoS Med,2020,17(9):e1003302.
［27］ KEUM N,GREENWOOD DC,LEE DH,et al.Adult weight gain and adiposity-related cancers:a dose-response meta-analysis of prospective observational studies［J］.J Natl Cancer Inst,2015,107(2):djv088.
［28］ LEY SH,ARDISSON KORAT AV,SUN Q,et al.Contribution of the nurses' health studies to uncovering risk factors for type 2 diabetes:diet,lifestyle,biomarkers,and genetics［J］.Am J Public Health,2016,106(9):1624-1630.
［29］ WANG X,SIMPSON ER,BROWN KA.Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer［J］.J Steroid Biochem Mol Biol,2015,153:35-44.
［30］ MAIR KM,GAW R,MACLEAN MR.Obesity,estrogens and adipose tissue dysfunction-implications for pulmonary arterial hypertension［J］.Pulm Circ,2020,10(3):2045894020952019.
［31］ GOLDIN BR,ADLERCREUTZ H,GORBACH SL,et al.Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women［J］.New England Journal of Medicine,1982,307(25):1542-1547.
［32］ GORBACH SL,GOLDIN BR.Diet and the excretion and enterohepatic cycling of estrogens［J］.Prev Med,1987,16(4):525-531.
［33］ SUZUKI R,RYLANDER-RUDQVIST T,YE W,et al.Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status-a prospective cohort study among Swedish women［J］.Int J Cancer,2008,122(2):403-412.
［34］ DE CICCO P,CATANI MV,GASPERI V,et al.Nutrition and breast cancer:a literature review on prevention,treatment and recurrence［J］.Nutrients,2019,11(7):1514.
［35］ MUEGGE BD,KUCZYNSKI J,KNIGHTS D,et al.Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans［J］.Science,2011,332(6032):970-974.
［36］ ERVIN SM,LI H,LIM L,et al.Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens［J］.Journal of Biological Chemistry,2019,294(49):18586-18599.
［37］ HELLAND T,HENNE N,BIFULCO E,et al.Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients［J］.Breast Cancer Res,2017,19(1):125.
［38］ WILL M,LIANG J,METCALFE C,et al.Therapeutic resistance to anti-oestrogen therapy in breast cancer［J］.Nature Reviews Cancer,2023,23(10):673-685.